IL-4 adenoviral gene therapy reduces inflammation, proinflammatory cytokines, vascularization, and bony destruction in rat adjuvant-induced arthritis

Journal of Immunology

Volumn 166, Issue 2, 2001, Pages 1214-1222

  Woods, J M ^a   Katschke K J , Jr ^a   Volin, M V ^a   Ruth, J H ^a   Woodruff, D C ^a   Asif Amin, M ^a   Connors, M A ^a   Kurata, H ^a   Arai, K I ^a   Haines III, G K ^a   Kumar, P ^a   Koch, A E ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; INTERLEUKIN 1BETA; INTERLEUKIN 4; MACROPHAGE INFLAMMATORY PROTEIN 2; RANTES; TUMOR NECROSIS FACTOR ALPHA;

ADENOVIRUS; ADJUVANT ARTHRITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANKLE; ARTICLE; BONE DESTRUCTION; CELL COUNT; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOSE RESPONSE; DRUG EFFECT; FEMALE; GENE THERAPY; INFLAMMATORY CELL; NONHUMAN; PAW EDEMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RHEUMATOID ARTHRITIS; SYNOVIUM; VASCULARIZATION;

EID: 0035863813     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.166.2.1214     Document Type: Article

References (40)

1. Adjuvant arthritis
2. Functions of IL-4 and control of its expression
3. Low levels of interleukin-4 and high levels of transforming growth factor β in rheumatoid synovitis
4. Quantitative analysis of cytokine gene expression in rheumatoid arthritis
5. Effects of IL-13 on phenotype, cytokine production, and cytotoxic function of human monocytes
6. Interleukin 4, but not interleukin 10, regulates the production of inflammation mediators by rheumatoid synoviocytes
7. IL-4 enhances programmed cell death (apoptosis) in stimulated human monocytes
8. Simultaneous disruption of interleukin (IL)-4- and IL-13 defines individual roles in T helper cell type 2-mediated responses
9. 2 by rheumatoid arthritis synovium ex vivo
10. Acting on the cytokine balance to control auto-immunity and chronic inflammation
11. Progress toward the treatment of arthritis by gene therapy
12. Gene transfer to synoviocytes: Prospects for gene treatment of arthritis
13. Gene therapy of rheumatoid arthritis via cytokine regulation: Future perspectives
14. Use of the rat adjuvant-induced arthritis as a model for rheumatoid arthritis gene therapy
15. Expression vector system based on the chicken β-actin promoter directs efficient production of interleukin-5
16. Construction of nondefective adenovirus type 5 bearing a 2.8-kilobase hepatitis B virus DNA near the right end of its genome
17. Cellular adhesion molecules in rat adjuvant arthritis
18. Suppression of arthritic bone destruction by adenovirus-mediated csk gene transfer to synoviocytes and osteoclasts
19. Suppression of collagen-induced arthritis through adenovirus-mediated transfer of a modified tumor necrosis factor α receptor gene
20. Temporal expression of inflammatory cytokines and chemokines in rat
21. Adenoviral vector-mediated overexpression of IL-4 in the knee joint of mice with collagen-induced arthritis prevents cartilage destruction
22. Intra-articular IL-4 gene therapy in arthritis: Anti-inflammatory effect and enhanced Th2 activity
23. Successful induction of adjuvant arthritis in mice by treatment with a monoclonal antibody against IL-4
24. Enhancement of T-cell-mediated arthritis in mice by treatment with a monoclonal antibody against interleukin-4
25. Effect of a monoclonal antibody against interleukin-4 on collagen-induced arthritis in mice
26. Role of interleukin-4 and interleukin-10 in murine collagen-induced arthritis
27. T cells cloned from human rheumatoid synovial membrane functionally represent the Th1 subset
28. The effect of human interleukin 1 on proteoglycan metabolism in human and porcine cartilage explants
29. In vivo gene expression of type 1 and type 2 cytokines in synovial tissues from patients in early stages of rheumatoid, reactive, and undifferentiated arthritis
30. Interleukin-4 inhibits bone resorption through an effect on osteoclasts and proinflammatory cytokines in an ex vivo model of bone resorption in rheumatoid arthritis
31. IL-4 gene therapy for collagen arthritis suppresses synovial IL-17 and osteoprotegerin ligand and prevents bone erosion
32. Interleukin 4 reverses T cell proliferative unresponsiveness and prevents the onset of diabetes in nonobese diabetic mice
33. Cytokine-induced immune deviation as a therapy for inflammatory autoimmune disease
34. Encapsulation in hollow fibres of xenogeneic cells engineered to secrete IL-4 or IL-13 ameliorates murine collagen-induced arthritis (CIA)
35. Collagen-induced arthritis in mice: Relationship of collagen-specific and total IgE synthesis to disease
36. Suppression of collagen-induced arthritis by continuous administration of IL-4
37. Suppression of monocyte function and differential regulation of IL-1 and IL- 1ra by IL-4 contribute to resolution of experimental arthritis
38. Inhibition of angiogenesis by interleukin 4
39. How tumors become angiogenic
40. Gene therapy for established murine collagen-induced arthritis by local and systemic adenovirus-mediated delivery of inteleukin-4